VaxNewMo is a healthcare firm that researches, develops and markets anti-bacterial vaccines for pneumococcal diseases.
Business Model:
Revenue: $2M
Employees: 2-10
Address: 20 South Sarah Avenue
City: St. Louis
State: MO
Zip: 63108
Country: US
VaxNewMo is a healthcare firm that researches, develops and markets anti-bacterial vaccines for pneumococcal diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Grant | 1 | $3.6M |
National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases |
11/2017 | Grant | 1 | $50k |
Arch Grants Arch Grants |
2/2020 | Grant | 1 | $3M |
BioGenerator BioGenerator |
1/2019 | Seed Round | 1 | - |
BioGenerator BioGenerator |
1/2019 | Seed Round | 1 | - |
BioGenerator BioGenerator |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|